Orchid Pharma gets US nod for Naratriptan Tabs ANDA

The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Naratriptan Tablets in the 1 mg and 2.5 mg strengths.

Naratriptan tablets are the generic equivalent of GSK’s Amerge tablets.